drugset / Trial / NCT02287181

A Phase IV Study Investigating the Effects of Remifentanil Concentrations on Propofol Requirements for Loss of Consciousness, Response to Painful Stimuli, Bispectral Index and Associated Haemodynamic Changes

NCT02287181 ↗

Phase 4 Completed 100 enrolled The University of Hong Kong
RandomizedParallel-groupTriple-blindTreatment

Summary

A prospective, randomised, phase IV trial including 150 patients. To evaluate the effects of varied concentrations of remifentanil on the proposal requirements for the loss of consciousness and response to pain and to evaluate the haemodynamic changes and processed EEG (BIS) during induction of anaesthesia.

Timeline

Start
2015-02
Primary completion
2015-08
Completion
2015-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 1 ug/ml Intravenous
Comparator Remifentanil Small molecule 0 ng/ml Intravenous
Comparator Remifentanil Small molecule 3 ng/ml Intravenous

Indications

No indication recorded.